Fulgent genetics, inc. (FLGT)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Revenue

32,528

21,351

18,730

-

-

-

Revenue

-

-

-

18,276

9,576

1,278

Cost of revenue

14,107

10,697

8,551

6,722

5,069

936

Gross profit

18,421

10,654

10,179

11,554

4,507

342

Operating expenses:
Research and development

6,537

5,534

4,223

3,558

4,431

521

Selling and marketing

5,898

4,652

4,205

2,469

2,670

581

General and administrative

6,414

5,538

5,233

4,609

2,418

230

Total operating expenses

18,849

15,724

13,661

10,636

9,519

1,332

Operating loss

-428

-5,070

-3,482

918

-5,012

-990

Interest and other income, net

837

434

-

-

-

-

Interest and other income, net

-

-

481

-5,386

27

0

Loss before income taxes and equity loss in investee

409

-4,636

-3,001

-4,468

-

-

Income (loss) before income taxes

-

-

-

-

-4,985

-990

Provision for income taxes

43

36

-1,015

920

0

0

Loss before equity loss in investee

366

-4,672

-1,986

-5,388

-

-

Equity loss in investee

-777

-935

-524

0

-

-

Income (loss) from continuing operations

-

-

-

-5,388

-4,985

-990

Income (loss) from discontinued operations

-

-

-

41

-3,329

-3,293

Net loss

-411

-5,607

-2,510

-5,347

-8,314

-4,283

Net loss per common share:
Basic

-0.02

-0.31

-

-

-

-

Diluted

-0.02

-0.31

-

-

-

-

Basic and Diluted

-

-

-0.14

-1.00

-0.61

0.00

Weighted-average common shares:
Basic

18,709

17,978

-

-

-

-

Diluted

18,709

17,978

-

-

-

-

Basic and Diluted

-

-

17,739

13,710

11,842

0